EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Albumin In Situ Hybridization in Genetically Characterized Cholangiocarcinoma and Tumors of Other Origins

Jay Shi, Sahar Hosseini, Evan Lang, Charlotte I Wang, Linda T Nieman, Vikram Desphande, David Ting, Lei Zhao

Modern Pathology · 2026-11 · 39 (11) · 101078

DOI: 10.1016/j.modpat.2026.101078 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Modern Pathology, 2026-11. Verfasst von Jay Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: shij@mskcc.org. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, In Situ Hybridization, Biomarkers, Tumor. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Incyte Corporation, Massachusetts General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsIn Situ HybridizationBiomarkers, TumorAlbuminsHumansIsocitrate DehydrogenaseMutationMaleFemaleMiddle AgedAgedAdult

Stichwörter der Autor:innen

FGFR2IDH1IDH2albumin in situ hybridizationcholangiocarcinomaintrahepatic cholangiocarcinoma

Substanzen

Isocitrate DehydrogenaseBiomarkers, TumorIDH1 protein, humanAlbuminsIDH2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: shij@mskcc.org.
  • Department of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
  • Mass General Brigham Cancer Institute, Harvard Medical School, Charlestown, Massachusetts.
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Mass General Brigham Cancer Institute, Harvard Medical School, Charlestown, Massachusetts. Electronic address: dting1@mgh.harvard.edu.

Förderung

  • Incyte Corporation
  • Massachusetts General Hospital

Zitieren

APA

Shi, J., Hosseini, S., Lang, E., Wang, C. I., Nieman, L. T., Desphande, V., Ting, D., & Zhao, L. (2026). Comparison of Albumin In Situ Hybridization in Genetically Characterized Cholangiocarcinoma and Tumors of Other Origins. Modern Pathology, 39(11), 101078. https://doi.org/10.1016/j.modpat.2026.101078

Vancouver

Shi J, Hosseini S, Lang E, Wang CI, Nieman LT, Desphande V, et al. Comparison of Albumin In Situ Hybridization in Genetically Characterized Cholangiocarcinoma and Tumors of Other Origins. Modern Pathology. 2026;39(11):101078. doi:10.1016/j.modpat.2026.101078

BibTeX
@article{Shi2026,
  author = {Shi, Jay and Hosseini, Sahar and Lang, Evan and Wang, Charlotte I and Nieman, Linda T and Desphande, Vikram and Ting, David and Zhao, Lei},
  title = {Comparison of Albumin In Situ Hybridization in Genetically Characterized Cholangiocarcinoma and Tumors of Other Origins},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {11},
  pages = {101078},
  doi = {10.1016/j.modpat.2026.101078}
}
Kostenlos starten →